clasp2 Antibody

What is CLASP2 and why is it significant in cellular research?

CLASP2 (Cytoplasmic Linker Associated Protein 2) is a 1,294 amino acid protein characterized by five HEAT repeats that functions as a microtubule plus-end tracking protein (+TIP). It plays crucial roles in regulating dynamic microtubule stability and ensuring proper polarization of cytoplasmic microtubule arrays in migrating cells . CLASP2's significance extends to multiple cellular processes including cytoskeletal organization, cell division, and insulin signaling. The protein is primarily localized in the cytoplasm, cytoskeleton, kinetochore, and Golgi apparatus, with particularly prominent expression in brain tissue . Its involvement in microtubule stabilization at both the cell cortex and kinetochore makes it essential for proper chromosomal alignment during mitosis and cellular migration, positioning CLASP2 as a critical target for research in cell biology, neuroscience, and metabolic studies .

How do I choose the appropriate CLASP2 antibody for my research application?

Selecting the right CLASP2 antibody requires careful consideration of several methodological factors. First, determine your experimental application needs, as different antibodies are optimized for specific techniques. For Western blotting, immunoprecipitation, immunofluorescence, immunohistochemistry, or ELISA applications, antibodies like the mouse monoclonal IgG1 kappa (F-3) have been validated across multiple species including mouse, rat, and human samples . For immunohistochemistry on paraffin-embedded tissues, the rat monoclonal antibody [KT68] has demonstrated effectiveness with mouse samples .

Second, consider species reactivity - ensure the antibody recognizes CLASP2 in your experimental model organism. For cross-species studies, verify that the antibody has been validated in all relevant species. Third, evaluate potential cross-reactivity with CLASP1, as some antibodies (like #2358) recognize both CLASP1 and CLASP2 . For isoform-specific studies, select antibodies that discriminate between CLASP2 beta and gamma isoforms. Finally, consider conjugated options for direct detection in techniques like immunofluorescence, where CLASP2 antibodies conjugated to fluorophores such as PE, FITC, or Alexa Fluor might offer advantages in multiplexed studies .

What controls should I implement when using CLASP2 antibodies in my experiments?

Implementing appropriate controls is critical for rigorous CLASP2 antibody-based experiments. For primary validation, include a positive control sample with known CLASP2 expression (e.g., brain tissue lysates or SH-SY5Y cells) . A negative control is equally important - either tissues/cells with CLASP2 knockdown or tissues naturally lacking CLASP2 expression. For immunoprecipitation studies, always include a non-immune IgG control performed under identical conditions, as demonstrated in interactome studies that employed normal IgG controls alongside CLASP2 antibody immunoprecipitations .

When performing RNAi experiments, validate knockdown efficiency through both Western blotting and immunofluorescence to confirm protein reduction. Studies have shown that after CLASP1+2 siRNA treatment, CLASP-specific signals were strongly reduced as assessed by FACS and immunofluorescence microscopy, with diminished signals at microtubule tips, Golgi, and centrosomes . For antibody specificity verification, consider overexpressing tagged CLASP2 constructs (e.g., GFP-CLASP2α) and confirming detection with your antibody of choice. This approach has been used to characterize cross-reactivity between CLASP1 and CLASP2 antibodies . Additionally, blocking peptides can be employed to confirm signal specificity in applications like immunohistochemistry.

How should I optimize Western blot protocols for detecting CLASP2?

Optimizing Western blot protocols for CLASP2 detection requires addressing several technical considerations. CLASP2 is a high molecular weight protein (~160 kDa), necessitating specific adjustments to standard protocols. First, use a lower percentage gel (5-8%) or gradient gel (5-20%) to achieve better resolution of high molecular weight proteins. Research has demonstrated successful CLASP2 detection using 5-20% SDS-PAGE gels run at 70V for stacking and 90V for resolving over 2-3 hours .

For protein extraction, an isotonic CHAPS lysis buffer has proven effective for CLASP2 isolation while maintaining protein interactions . Load adequate protein (≥30 μg per lane) under reducing conditions to ensure detection of this relatively low-abundance protein . During transfer, increase transfer time and use lower voltage to improve efficiency of large protein transfer to membrane.

For antibody incubation, dilution ratios between 1:500-1:1000 are typically effective for CLASP2 primary antibodies, though specific recommendations vary by manufacturer. When developing the blot, extended exposure times may be necessary, as CLASP2 signals can be relatively weak compared to housekeeping proteins. To confirm specificity, validated positive controls include HEK293, SH-SY5Y, and HL-60 whole cell lysates, as well as brain tissue lysates, which have all demonstrated detectable CLASP2 expression .

What is the optimal protocol for immunoprecipitating CLASP2 and its binding partners?

The optimal protocol for CLASP2 immunoprecipitation involves several critical steps to preserve protein-protein interactions while minimizing background. Begin with an appropriate lysis buffer - isotonic CHAPS lysis buffer has proven effective in preserving CLASP2 interactions during immunoprecipitation experiments . For cell lysis, use gentle conditions (avoid harsh detergents like SDS) to maintain protein-protein interactions.

Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding. Select an antibody with validated IP performance; the mouse monoclonal CLASP2 antibody (F-3) has been successfully used for immunoprecipitation of CLASP2 from multiple species . Incubate pre-cleared lysate with CLASP2 antibody overnight at 4°C with gentle rotation, followed by adding protein A/G beads and incubating for an additional 1-2 hours.

Perform stringent washing (at least 4-5 washes) with wash buffer containing low detergent concentration while maintaining salt concentration to preserve specific interactions. For elution, either use SDS sample buffer for direct Western blot analysis or consider gentler elution methods if downstream mass spectrometry is planned.

For identification of novel binding partners, affinity purification coupled with mass spectrometry (AP-MS) has been successfully implemented for CLASP2. This approach, combined with label-free quantitative proteomics and analysis using Significance Analysis of Interactome (SAINT), has identified novel CLASP2 interacting proteins including SOGA1, MARK2, and G2L1 . Always include a parallel non-immune IgG control IP to distinguish specific from non-specific interactions.

How can I effectively visualize CLASP2 localization using immunofluorescence techniques?

Effective visualization of CLASP2 through immunofluorescence requires optimized fixation, permeabilization, and staining protocols. Begin with appropriate fixation - 4% paraformaldehyde (10-15 minutes at room temperature) preserves most CLASP2 epitopes while maintaining cellular architecture. For microtubule-associated CLASP2, methanol fixation (-20°C, 5-10 minutes) may better preserve microtubule structures. Permeabilize with 0.1-0.2% Triton X-100 in PBS (5-10 minutes), being careful not to over-permeabilize, which can disrupt cytoskeletal structures.

Blocking is critical - use 5% normal serum (matching the secondary antibody host) with 1% BSA in PBS for 30-60 minutes at room temperature. For primary antibody incubation, both mouse monoclonal (F-3) and rat monoclonal [KT68] antibodies have been validated for immunofluorescence applications . Dilute according to manufacturer recommendations (typically 1:100-1:500) and incubate overnight at 4°C in a humidified chamber.

For optimal visualization of CLASP2's diverse subcellular localizations, consider dual or triple staining with markers for: microtubule plus-ends (EB1), cell cortex (cortactin), kinetochores (CENP-E), or Golgi (GM130). This is particularly important as CLASP2 displays distinct localization patterns at microtubule tips, Golgi, and centrosomes . Use high-quality fluorophore-conjugated secondary antibodies (1:500-1:1000, 1 hour at room temperature) and include DAPI for nuclear counterstaining.

For confocal microscopy, z-stack imaging is recommended to fully capture CLASP2 localization throughout the cell volume. Maximum intensity projections can then be created for visualization, while retaining original z-stack data for detailed analysis of co-localization with other cellular structures.

What are common pitfalls in CLASP2 antibody experiments and how can I resolve them?

Several common pitfalls can affect CLASP2 antibody experiments, each requiring specific troubleshooting approaches. One significant issue is cross-reactivity with CLASP1, as these proteins share considerable homology. Studies have shown that many CLASP2 antibodies display some cross-reactivity with GFP-CLASP1α, while CLASP1 antibodies similarly cross-react with GFP-CLASP2α . To address this, validate antibody specificity using cells with CLASP1 or CLASP2 knockdown, or test multiple antibodies targeting different epitopes.

Another common issue is weak signal detection in Western blotting, since CLASP2 is a relatively low-abundance protein. To improve detection: (1) increase protein loading to 30-50 μg per lane, (2) optimize gel percentage (5-20% gradient gels work well) , (3) extend primary antibody incubation to overnight at 4°C, and (4) utilize enhanced chemiluminescence detection systems or consider more sensitive detection methods.

For immunofluorescence experiments, high background staining can obscure specific CLASP2 signals. Analysis of CLASP1+2 knockdown cells has revealed that cells often display a dim diffuse pattern partly due to background staining, while specific signals at microtubule tips, Golgi, and centrosomes are diminished in knockdown cells . To reduce background: (1) increase blocking time or blocking agent concentration, (2) optimize antibody dilutions with titration experiments, (3) add 0.1% Tween-20 to antibody dilution buffers, and (4) perform additional washing steps.

For immunoprecipitation, low recovery of CLASP2 or interacting partners may occur. To improve results: (1) use a lysis buffer demonstrated to preserve CLASP2 interactions, such as isotonic CHAPS buffer , (2) reduce detergent concentration during washing steps, and (3) consider crosslinking the antibody to beads to prevent antibody contamination in the eluted sample.

How do I distinguish between CLASP1 and CLASP2 in experimental systems?

Distinguishing between CLASP1 and CLASP2 requires careful methodology due to their structural similarity and potential antibody cross-reactivity. Western blot analysis provides one approach, as CLASP1 and CLASP2 migrate at slightly different molecular weights (~160 kDa), though the difference is subtle. Studies have characterized multiple antibodies including #402 and #2292 (which strongly react with GFP-CLASP1α and display some cross-reactivity with GFP-CLASP2α) and antibody #2358 (which strongly reacts with GFP-CLASP2α and cross-reacts somewhat with GFP-CLASP1α) . Using these antibodies in parallel can help distinguish between the proteins based on relative signal strength.

RNA interference provides a more definitive approach. Specific siRNAs targeting CLASP1 or CLASP2 have been validated and can be used to selectively deplete each protein. Sequential immunoblotting with both CLASP1- and CLASP2-specific antibodies on the same samples can then reveal the specificity of knockdown. FACS analysis after staining with CLASP antibodies has also been used to evaluate knockdown efficiency .

For immunofluorescence studies, isoform-specific localization patterns may help distinguish the proteins. While both localize to microtubule plus-ends, differences in their distribution at other cellular locations such as the Golgi apparatus may be observed. Moreover, co-staining with known specific interaction partners of each protein can provide additional evidence for distinguishing between CLASP1 and CLASP2.

RT-PCR and qPCR offer additional specificity through designing primers targeting non-conserved regions. For cloning and studying mouse CLASP2 specifically, primers like 5′-ggccatgtgaactattaggagctattctagggtg-3′ (sense) and 5′-gcagccagttgtcctctcagagactgggaggcg-3′ (antisense) have been validated , which could be adapted for detection purposes.

How should I quantify and statistically analyze CLASP2 expression across different experimental conditions?

Accurate quantification and statistical analysis of CLASP2 expression requires careful methodological consideration across different experimental platforms. For Western blot quantification, densitometric analysis should be performed on multiple independent experiments (n≥3). Normalize CLASP2 band intensity to loading controls such as β-actin, GAPDH, or total protein stain (preferred for high molecular weight proteins). Use analysis software with background subtraction capabilities to improve accuracy. Statistical comparison between conditions should employ appropriate tests based on data distribution (t-test for two conditions, ANOVA with post-hoc tests for multiple conditions).

When analyzing CLASP2 interaction partners through immunoprecipitation-mass spectrometry, tools like Significance Analysis of Interactome (SAINT) have proven effective, as demonstrated in studies identifying novel CLASP2 binding partners . This approach allows statistical evaluation of protein-protein interactions across multiple experimental replicates.

For mRNA expression analysis by qRT-PCR, implement the 2^(-ΔΔCt) method with appropriate reference genes validated for stability in your experimental system. CLASP2 isoform-specific primers should be validated for specificity and efficiency prior to experimental use.

How can I investigate CLASP2 phosphorylation states and their functional significance?

Investigating CLASP2 phosphorylation requires multi-faceted approaches to identify modification sites and their functional impacts. CLASP2 undergoes phosphorylation by glycogen synthase kinase 3 beta (GSK3β), which reduces its microtubule-binding capacity . To study these modifications, begin with phospho-specific antibodies if available, or use general phospho-serine/threonine antibodies on immunoprecipitated CLASP2. For comprehensive phospho-site mapping, immunoprecipitate CLASP2 followed by mass spectrometry analysis using titanium dioxide (TiO2) enrichment of phosphopeptides.

To manipulate phosphorylation states experimentally, several strategies have proven effective. Insulin stimulation has been shown to induce CLASP2 phosphorylation and relocalization with reorganized actin and GLUT4 at the plasma membrane . Alternatively, use GSK3β inhibitors (e.g., CHIR99021, lithium chloride) to prevent CLASP2 phosphorylation, or constitutively active GSK3β to enhance phosphorylation. For site-specific analysis, generate phosphomimetic (serine/threonine to glutamate) or phospho-deficient (serine/threonine to alanine) CLASP2 mutants through site-directed mutagenesis.

Functional analysis of phosphorylation states can be assessed through several approaches. Live cell imaging of fluorescently-tagged wild-type versus phospho-mutant CLASP2 can reveal differences in microtubule plus-end tracking, cortical association, or Golgi localization. Microtubule stability assays comparing cells expressing different CLASP2 phospho-variants can determine functional consequences on cytoskeletal dynamics. Co-immunoprecipitation experiments comparing binding partner profiles between phospho-states can identify phosphorylation-dependent protein interactions.

For pathway integration analysis, combine CLASP2 phosphorylation studies with inhibitors of upstream kinases (PI3K, Akt) or activators of phosphatases to establish signaling hierarchies regulating CLASP2 function in processes like cell migration, division, or insulin signaling.

What methodologies can I use to study CLASP2 interactions with the microtubule cytoskeleton?

Studying CLASP2 interactions with microtubules requires specialized methodologies spanning in vitro and cellular approaches. For direct interaction studies, purify recombinant CLASP2 protein (full-length or functional domains) and perform in vitro microtubule co-sedimentation assays. This approach can determine binding affinity and stoichiometry under defined conditions, with the option to include purified binding partners or kinases to assess regulatory mechanisms.

In cellular contexts, fluorescence recovery after photobleaching (FRAP) provides valuable insights into CLASP2-microtubule dynamics. By expressing fluorescently-tagged CLASP2 and photobleaching regions of interest (microtubule plus-ends, cell cortex), the recovery kinetics reveal CLASP2's association/dissociation rates with microtubules under different experimental conditions. This approach can determine how interactions with proteins like EB1, EB3, ELKS, and CLIP-115 influence CLASP2 dynamics .

Total internal reflection fluorescence (TIRF) microscopy offers another powerful approach, enabling visualization of single molecules of fluorescently-labeled CLASP2 interacting with microtubules in vitro or at the cell cortex. This technique has revealed that CLASP2 may enhance the frequency of rescue of depolymerizing microtubules by attaching their plus-ends to cortical platforms composed of ERC1 and PHLDB2 .

To study CLASP2's role in microtubule nucleation from the trans-Golgi network, live-cell imaging with dual-labeled CLASP2 and Golgi markers, combined with microtubule regrowth assays following nocodazole washout, can reveal the temporal and spatial dynamics of CLASP2-mediated microtubule organization. For kinetochore-associated functions, immunofluorescence with kinetochore markers during mitosis can assess CLASP2's role in bipolar alignment of chromosomes on the mitotic spindle .

Proximity ligation assays (PLA) provide an additional approach to visualize and quantify interactions between CLASP2 and specific microtubule-associated proteins in situ, offering spatial resolution of interaction sites within the cell.

How can I develop and validate CLASP2 knockdown or knockout models for functional studies?

Developing robust CLASP2 knockdown or knockout models requires careful design and comprehensive validation strategies. For transient knockdown, siRNA approaches have been well-established. Previous studies successfully used CLASP-specific siRNAs that effectively reduced CLASP-specific signals at microtubule tips, Golgi, and centrosomes . When designing siRNAs, target sequences unique to CLASP2 to avoid affecting CLASP1 expression. For optimal knockdown, test multiple siRNA sequences and concentrations, and validate efficiency 48-72 hours post-transfection by both Western blotting and immunofluorescence.

For stable knockdown, shRNA expression via lentiviral vectors provides longer-term protein reduction. Select puromycin or another appropriate selection marker to establish stable cell lines, and verify knockdown maintenance over multiple passages. For inducible systems, consider tetracycline-inducible shRNA expression to control the timing and degree of CLASP2 depletion.

CRISPR-Cas9 gene editing offers the most definitive approach for complete CLASP2 knockout. Design guide RNAs targeting early exons common to all CLASP2 isoforms, or target specific exons for isoform-selective knockout. To increase editing efficiency, use multiple guide RNAs and perform careful clone selection and expansion. For essential genes like CLASP2, consider conditional knockout strategies using loxP/Cre systems.

Comprehensive validation is critical and should include:

• Genomic verification through PCR and sequencing of the targeted locus

• Transcript analysis by RT-qPCR using primers spanning multiple exons

• Protein verification by Western blotting and immunofluorescence using antibodies recognizing different CLASP2 epitopes

• Functional validation examining established CLASP2-dependent processes (microtubule dynamics, cell migration, chromosome alignment)

For rescue experiments, express siRNA/shRNA-resistant or CRISPR-resistant CLASP2 constructs (with synonymous mutations at the target sites) to confirm specificity of observed phenotypes. When cloning mouse CLASP2 cDNA for rescue experiments, validated primers (5′-ggccatgtgaactattaggagctattctagggtg-3′ and 5′-gcagccagttgtcctctcagagactgggaggcg-3′) can be employed, generating sequence identical to reference NM_001081960.1 .

What approaches can be used to study the role of CLASP2 in insulin signaling and glucose metabolism?

Investigating CLASP2's role in insulin signaling and glucose metabolism requires integrated approaches spanning molecular, cellular, and physiological techniques. CLASP2 has been identified as a protein that undergoes insulin-stimulated phosphorylation and co-localization with reorganized actin and GLUT4 at the plasma membrane , suggesting important metabolic functions.

At the molecular level, study insulin-stimulated CLASP2 phosphorylation through immunoprecipitation followed by phospho-specific Western blotting or mass spectrometry. Time-course experiments can establish the kinetics of CLASP2 phosphorylation following insulin stimulation. Identify the specific kinases involved using selective inhibitors or kinase knockdown approaches, focusing on insulin pathway components like PI3K, Akt, and GSK3β.

For subcellular localization studies, use confocal microscopy to track CLASP2 redistribution following insulin stimulation. Co-staining with GLUT4 and actin markers can reveal temporal and spatial relationships between CLASP2 and glucose transport machinery. Live-cell imaging with fluorescently-tagged CLASP2 and GLUT4 provides dynamic visualization of these processes.

To establish functional significance, develop CLASP2 knockdown or knockout models in insulin-responsive cell lines like 3T3-L1 adipocytes, which have been used successfully in CLASP2 interactome studies . Measure the impact on insulin-stimulated glucose uptake using radiolabeled glucose assays, and assess GLUT4 translocation efficiency through cell surface biotinylation or TIRF microscopy of fluorescently-tagged GLUT4.

For mechanistic insights, investigate how CLASP2 interacts with the novel protein SOGA1, the microtubule-associated protein kinase MARK2, and the microtubule/actin-regulating protein G2L1, which have been identified as CLASP2 binding partners in adipocytes . Determine whether these interactions are insulin-regulated and how they contribute to metabolic functions.

In more advanced systems, consider generating tissue-specific CLASP2 knockout mouse models in metabolically relevant tissues (adipose, muscle, liver) to assess whole-body glucose homeostasis through glucose tolerance tests, insulin tolerance tests, and hyperinsulinemic-euglycemic clamps.

What emerging technologies might enhance CLASP2 antibody-based research?

Several emerging technologies hold promise for advancing CLASP2 antibody-based research beyond current capabilities. Single-cell proteomics approaches combined with CLASP2 antibodies could reveal cell-to-cell variation in expression levels and phosphorylation states, particularly valuable in heterogeneous tissues like brain where CLASP2 expression is prominent . This would provide insights into how CLASP2 function varies across cell types or cell cycle stages.

CRISPR-based endogenous tagging of CLASP2 (such as split-GFP or HaloTag knock-ins) paired with specific antibodies could enable visualization of native CLASP2 without overexpression artifacts. This approach maintains physiological expression levels while providing versatility for live-cell imaging and biochemical purification.

Advanced spatial proteomics techniques like multiplexed ion beam imaging (MIBI) or co-detection by indexing (CODEX) using CLASP2 antibodies could map its distribution across tissue sections with subcellular resolution, correlating with multiple markers simultaneously. This would be particularly valuable for understanding CLASP2's diverse roles at microtubule tips, Golgi, and centrosomes .

Proximity-dependent labeling methods (BioID, TurboID, APEX) fused to CLASP2 could complement traditional antibody-based co-immunoprecipitation approaches, allowing identification of transient or context-specific interaction partners in living cells. This would extend beyond the interactome already established in 3T3-L1 adipocytes that identified SOGA1, MARK2, and G2L1 as binding partners .

Finally, nanobody or single-domain antibody development against CLASP2 could overcome limitations of conventional antibodies, offering smaller probes with potentially better access to sterically hindered epitopes within dense cytoskeletal structures. These could be expressed intracellularly as "intrabodies" to track or functionally modulate CLASP2 in living cells.

How might CLASP2 research contribute to understanding neurodegenerative and metabolic disorders?

CLASP2 research has significant potential to illuminate mechanisms underlying both neurodegenerative and metabolic disorders through several interconnected pathways. CLASP2's prominent expression in brain tissue and critical role in microtubule stabilization positions it as relevant to neurodegenerative conditions where cytoskeletal abnormalities feature prominently . Microtubule dysfunction is implicated in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, where axonal transport defects contribute to pathogenesis. Studying how CLASP2 regulates neuronal microtubule dynamics could reveal novel therapeutic targets for preserving cytoskeletal integrity in these conditions.

CLASP2's phosphorylation by GSK3β, which reduces its microtubule-binding capacity , provides another connection to neurodegeneration. GSK3β hyperactivity is implicated in tau hyperphosphorylation in Alzheimer's disease. Investigating whether abnormal CLASP2 phosphorylation occurs in disease models and how this affects neuronal microtubule stability could reveal previously unrecognized disease mechanisms.

In metabolic disorders, CLASP2's insulin-stimulated phosphorylation and co-localization with reorganized actin and GLUT4 at the plasma membrane suggests a role in glucose homeostasis . Insulin resistance in type 2 diabetes disrupts GLUT4 translocation, and if CLASP2 dysfunction contributes to this process, it could represent a novel therapeutic target. The identification of SOGA1 (Suppressor Of Glucose by Autophagy) as a CLASP2 binding partner further strengthens the connection to metabolic regulation .

The intersection of metabolic dysfunction and neurodegeneration is increasingly recognized in conditions like Alzheimer's disease, sometimes termed "type 3 diabetes." CLASP2's dual roles in both microtubule dynamics and insulin signaling position it uniquely at this crossroads, potentially providing mechanistic insights into how metabolic dysregulation contributes to neurodegeneration.

Future therapeutic approaches might target CLASP2 phosphorylation, specific protein-protein interactions, or isoform-specific functions to modulate its activity in disease contexts, making continued development of specific antibodies and small molecule modulators important research goals.